Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats

Minoru Kawamura, Graeme Eisenhofer, Irwin J. Kopin, Peter F. Kador, Yong S. Lee, Jen Yue Tsai, Shigeki Fujisawa, Martin J. Lizak, Andrea Sinz, Sanai Sato

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The sympathoneural neurotransmitter norepinephrine (NE) is deaminated to 3,4-dihydroxymandelaldehyde (DHMAL) and subsequently converted to either 3,4-dihydroxymandelic acid (DHMA) or 3,4-dihydroxyphenylglycol (DHPG). In this study, we investigated the relative importance of aldose reductase versus aldehyde reductase in the formation of DHPG from DHMAL. The in vitro incubation of NE with aldose reductase in the presence of monoamine oxidase (MAO) resulted in the formation of DHPG, which was confirmed by mass spectrometry. Although aldehyde reductase also generated DHPG, its activity was much lower than that of aldose reductase. With northern blotting, the expression of both aldose reductase and aldehyde reductase was detected in rat superior cervical ganglia. However, with western blotting, only aldose reductase was immunologically detectable. Treatment of rats with aldose reductase inhibitors for 3 days increased the plasma level of DHMA. There was no correlation between the selectivity of inhibitors and effects on NE metabolite levels. A significant decrease in DHPG, however, was obtained only with an extremely high dose (9 mg/kg/day) of the nonselective inhibitor AL 1576. The present study confirmed that aldose reductase generates DHPG from NE in the presence of MAO. In rat sympathetic neurons, aldose reductase appears to be more important than aldehyde reductase for the formation of DHPG. However, when aldose reductase is inhibited, it appears that aldehyde reductase can compensate for the conversion of DHMAL to DHPG, indicating redundancy in the reduction pathway. Copyright (C) 1999 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)517-524
Number of pages8
JournalBiochemical Pharmacology
Volume58
Issue number3
DOIs
StatePublished - Aug 1 1999

Fingerprint

Aldehyde Reductase
Deamination
Rats
Norepinephrine
Enzymes
Monoamine Oxidase
Superior Cervical Ganglion
Metabolites
Northern Blotting
Neurons
Mass spectrometry

Keywords

  • 3,4-dihydroxymandelaldehyde
  • 3,4-dihydroxyphenylglycol
  • Aldehyde reductase
  • Aldose reductase
  • Norepinephrine
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats. / Kawamura, Minoru; Eisenhofer, Graeme; Kopin, Irwin J.; Kador, Peter F.; Lee, Yong S.; Tsai, Jen Yue; Fujisawa, Shigeki; Lizak, Martin J.; Sinz, Andrea; Sato, Sanai.

In: Biochemical Pharmacology, Vol. 58, No. 3, 01.08.1999, p. 517-524.

Research output: Contribution to journalArticle

Kawamura, M, Eisenhofer, G, Kopin, IJ, Kador, PF, Lee, YS, Tsai, JY, Fujisawa, S, Lizak, MJ, Sinz, A & Sato, S 1999, 'Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats', Biochemical Pharmacology, vol. 58, no. 3, pp. 517-524. https://doi.org/10.1016/S0006-2952(99)00121-5
Kawamura, Minoru ; Eisenhofer, Graeme ; Kopin, Irwin J. ; Kador, Peter F. ; Lee, Yong S. ; Tsai, Jen Yue ; Fujisawa, Shigeki ; Lizak, Martin J. ; Sinz, Andrea ; Sato, Sanai. / Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats. In: Biochemical Pharmacology. 1999 ; Vol. 58, No. 3. pp. 517-524.
@article{d32bc9d1e5124b13aa5d354c8a5f4c7d,
title = "Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats",
abstract = "The sympathoneural neurotransmitter norepinephrine (NE) is deaminated to 3,4-dihydroxymandelaldehyde (DHMAL) and subsequently converted to either 3,4-dihydroxymandelic acid (DHMA) or 3,4-dihydroxyphenylglycol (DHPG). In this study, we investigated the relative importance of aldose reductase versus aldehyde reductase in the formation of DHPG from DHMAL. The in vitro incubation of NE with aldose reductase in the presence of monoamine oxidase (MAO) resulted in the formation of DHPG, which was confirmed by mass spectrometry. Although aldehyde reductase also generated DHPG, its activity was much lower than that of aldose reductase. With northern blotting, the expression of both aldose reductase and aldehyde reductase was detected in rat superior cervical ganglia. However, with western blotting, only aldose reductase was immunologically detectable. Treatment of rats with aldose reductase inhibitors for 3 days increased the plasma level of DHMA. There was no correlation between the selectivity of inhibitors and effects on NE metabolite levels. A significant decrease in DHPG, however, was obtained only with an extremely high dose (9 mg/kg/day) of the nonselective inhibitor AL 1576. The present study confirmed that aldose reductase generates DHPG from NE in the presence of MAO. In rat sympathetic neurons, aldose reductase appears to be more important than aldehyde reductase for the formation of DHPG. However, when aldose reductase is inhibited, it appears that aldehyde reductase can compensate for the conversion of DHMAL to DHPG, indicating redundancy in the reduction pathway. Copyright (C) 1999 Elsevier Science Inc.",
keywords = "3,4-dihydroxymandelaldehyde, 3,4-dihydroxyphenylglycol, Aldehyde reductase, Aldose reductase, Norepinephrine, Sympathetic nervous system",
author = "Minoru Kawamura and Graeme Eisenhofer and Kopin, {Irwin J.} and Kador, {Peter F.} and Lee, {Yong S.} and Tsai, {Jen Yue} and Shigeki Fujisawa and Lizak, {Martin J.} and Andrea Sinz and Sanai Sato",
year = "1999",
month = "8",
day = "1",
doi = "10.1016/S0006-2952(99)00121-5",
language = "English (US)",
volume = "58",
pages = "517--524",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats

AU - Kawamura, Minoru

AU - Eisenhofer, Graeme

AU - Kopin, Irwin J.

AU - Kador, Peter F.

AU - Lee, Yong S.

AU - Tsai, Jen Yue

AU - Fujisawa, Shigeki

AU - Lizak, Martin J.

AU - Sinz, Andrea

AU - Sato, Sanai

PY - 1999/8/1

Y1 - 1999/8/1

N2 - The sympathoneural neurotransmitter norepinephrine (NE) is deaminated to 3,4-dihydroxymandelaldehyde (DHMAL) and subsequently converted to either 3,4-dihydroxymandelic acid (DHMA) or 3,4-dihydroxyphenylglycol (DHPG). In this study, we investigated the relative importance of aldose reductase versus aldehyde reductase in the formation of DHPG from DHMAL. The in vitro incubation of NE with aldose reductase in the presence of monoamine oxidase (MAO) resulted in the formation of DHPG, which was confirmed by mass spectrometry. Although aldehyde reductase also generated DHPG, its activity was much lower than that of aldose reductase. With northern blotting, the expression of both aldose reductase and aldehyde reductase was detected in rat superior cervical ganglia. However, with western blotting, only aldose reductase was immunologically detectable. Treatment of rats with aldose reductase inhibitors for 3 days increased the plasma level of DHMA. There was no correlation between the selectivity of inhibitors and effects on NE metabolite levels. A significant decrease in DHPG, however, was obtained only with an extremely high dose (9 mg/kg/day) of the nonselective inhibitor AL 1576. The present study confirmed that aldose reductase generates DHPG from NE in the presence of MAO. In rat sympathetic neurons, aldose reductase appears to be more important than aldehyde reductase for the formation of DHPG. However, when aldose reductase is inhibited, it appears that aldehyde reductase can compensate for the conversion of DHMAL to DHPG, indicating redundancy in the reduction pathway. Copyright (C) 1999 Elsevier Science Inc.

AB - The sympathoneural neurotransmitter norepinephrine (NE) is deaminated to 3,4-dihydroxymandelaldehyde (DHMAL) and subsequently converted to either 3,4-dihydroxymandelic acid (DHMA) or 3,4-dihydroxyphenylglycol (DHPG). In this study, we investigated the relative importance of aldose reductase versus aldehyde reductase in the formation of DHPG from DHMAL. The in vitro incubation of NE with aldose reductase in the presence of monoamine oxidase (MAO) resulted in the formation of DHPG, which was confirmed by mass spectrometry. Although aldehyde reductase also generated DHPG, its activity was much lower than that of aldose reductase. With northern blotting, the expression of both aldose reductase and aldehyde reductase was detected in rat superior cervical ganglia. However, with western blotting, only aldose reductase was immunologically detectable. Treatment of rats with aldose reductase inhibitors for 3 days increased the plasma level of DHMA. There was no correlation between the selectivity of inhibitors and effects on NE metabolite levels. A significant decrease in DHPG, however, was obtained only with an extremely high dose (9 mg/kg/day) of the nonselective inhibitor AL 1576. The present study confirmed that aldose reductase generates DHPG from NE in the presence of MAO. In rat sympathetic neurons, aldose reductase appears to be more important than aldehyde reductase for the formation of DHPG. However, when aldose reductase is inhibited, it appears that aldehyde reductase can compensate for the conversion of DHMAL to DHPG, indicating redundancy in the reduction pathway. Copyright (C) 1999 Elsevier Science Inc.

KW - 3,4-dihydroxymandelaldehyde

KW - 3,4-dihydroxyphenylglycol

KW - Aldehyde reductase

KW - Aldose reductase

KW - Norepinephrine

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0032973893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032973893&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(99)00121-5

DO - 10.1016/S0006-2952(99)00121-5

M3 - Article

C2 - 10424772

AN - SCOPUS:0032973893

VL - 58

SP - 517

EP - 524

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 3

ER -